237 related articles for article (PubMed ID: 22365348)
41. Selective carbohydrate utilization by lactobacilli and bifidobacteria.
Watson D; O'Connell Motherway M; Schoterman MH; van Neerven RJ; Nauta A; van Sinderen D
J Appl Microbiol; 2013 Apr; 114(4):1132-46. PubMed ID: 23240984
[TBL] [Abstract][Full Text] [Related]
42. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro.
Palframan RJ; Gibson GR; Rastall RA
Anaerobe; 2002 Oct; 8(5):287-92. PubMed ID: 16887671
[TBL] [Abstract][Full Text] [Related]
43. Review article: prebiotics in the gastrointestinal tract.
Macfarlane S; Macfarlane GT; Cummings JH
Aliment Pharmacol Ther; 2006 Sep; 24(5):701-14. PubMed ID: 16918875
[TBL] [Abstract][Full Text] [Related]
44. Detailed kinetic model describing new oligosaccharides synthesis using different β-galactosidases.
Rodriguez-Fernandez M; Cardelle-Cobas A; Villamiel M; Banga JR
J Biotechnol; 2011 May; 153(3-4):116-24. PubMed ID: 21440015
[TBL] [Abstract][Full Text] [Related]
45. In vitro evaluation of the fermentation properties of galactooligosaccharides synthesised by alpha-galactosidase from Lactobacillus reuteri.
Tzortzis G; Goulas AK; Baillon ML; Gibson GR; Rastall RA
Appl Microbiol Biotechnol; 2004 Mar; 64(1):106-11. PubMed ID: 13680200
[TBL] [Abstract][Full Text] [Related]
46. Developing a quantitative approach for determining the in vitro prebiotic potential of dietary oligosaccharides.
Vulevic J; Rastall RA; Gibson GR
FEMS Microbiol Lett; 2004 Jul; 236(1):153-9. PubMed ID: 15212805
[TBL] [Abstract][Full Text] [Related]
47. Selection and optimization procedure of synbiotic for cholesterol removal.
Zhang F; Hang X; Fan X; Li G; Yang H
Anaerobe; 2007; 13(5-6):185-92. PubMed ID: 17681806
[TBL] [Abstract][Full Text] [Related]
48. Functional petit-suisse cheese: measure of the prebiotic effect.
Cardarelli HR; Saad SM; Gibson GR; Vulevic J
Anaerobe; 2007; 13(5-6):200-7. PubMed ID: 17611130
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of prebiotic carbohydrates derived from cheese whey permeate by a combined process of isomerisation and transgalactosylation.
Corzo-Martínez M; Copoví P; Olano A; Moreno FJ; Montilla A
J Sci Food Agric; 2013 May; 93(7):1591-7. PubMed ID: 23096763
[TBL] [Abstract][Full Text] [Related]
50. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures.
Mäkeläinen H; Saarinen M; Stowell J; Rautonen N; Ouwehand AC
Benef Microbes; 2010 Jun; 1(2):139-48. PubMed ID: 21840802
[TBL] [Abstract][Full Text] [Related]
51. Maple sap as a rich medium to grow probiotic lactobacilli and to produce lactic acid.
Cochu A; Fourmier D; Halasz A; Hawari J
Lett Appl Microbiol; 2008 Dec; 47(6):500-7. PubMed ID: 19120917
[TBL] [Abstract][Full Text] [Related]
52. Effects of prebiotic oligosaccharides and trehalose on growth and production of bacteriocins by lactic acid bacteria.
Chen YS; Srionnual S; Onda T; Yanagida F
Lett Appl Microbiol; 2007 Aug; 45(2):190-3. PubMed ID: 17651217
[TBL] [Abstract][Full Text] [Related]
53. [Characteristics of Lactobacillus strains contained in pharmaceuticals].
Banach W; Bucholc B; Wójcik B
Med Dosw Mikrobiol; 2001; 53(2):143-9. PubMed ID: 11757423
[TBL] [Abstract][Full Text] [Related]
54. Use of whey permeate containing in situ synthesised galacto-oligosaccharides for the growth and preservation of Lactobacillus plantarum.
Golowczyc M; Vera C; Santos M; Guerrero C; Carasi P; Illanes A; Gómez-Zavaglia A; Tymczyszyn E
J Dairy Res; 2013 Aug; 80(3):374-81. PubMed ID: 23876605
[TBL] [Abstract][Full Text] [Related]
55. Probiotic potential of 3 Lactobacilli strains isolated from breast milk.
Martín R; Olivares M; Marín ML; Fernández L; Xaus J; Rodríguez JM
J Hum Lact; 2005 Feb; 21(1):8-17; quiz 18-21, 41. PubMed ID: 15681631
[TBL] [Abstract][Full Text] [Related]
56. Dietary modulation of gut functional ecology studied by fecal metabonomics.
Martin FP; Sprenger N; Montoliu I; Rezzi S; Kochhar S; Nicholson JK
J Proteome Res; 2010 Oct; 9(10):5284-95. PubMed ID: 20806900
[TBL] [Abstract][Full Text] [Related]
57. A combined metabolomic and phylogenetic study reveals putatively prebiotic effects of high molecular weight arabino-oligosaccharides when assessed by in vitro fermentation in bacterial communities derived from humans.
Sulek K; Vigsnaes LK; Schmidt LR; Holck J; Frandsen HL; Smedsgaard J; Skov TH; Meyer AS; Licht TR
Anaerobe; 2014 Aug; 28():68-77. PubMed ID: 24905430
[TBL] [Abstract][Full Text] [Related]
58. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
[TBL] [Abstract][Full Text] [Related]
59. In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12.
Martinez RC; Aynaou AE; Albrecht S; Schols HA; De Martinis EC; Zoetendal EG; Venema K; Saad SM; Smidt H
Int J Food Microbiol; 2011 Sep; 149(2):152-8. PubMed ID: 21741105
[TBL] [Abstract][Full Text] [Related]
60. Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes.
Goh YJ; Klaenhammer TR
Annu Rev Food Sci Technol; 2015; 6():137-56. PubMed ID: 25532597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
